Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 15 Plasma cell 13 Other hematologic neoplasm 12 Gastrointestinal 6 CNS 6 Genitourinary 4 Breast 4 Thoracic 3 Sarcoma 3 Myeloid 3 Gynecologic 3 Other 2 Head & Neck 2 Dermatologic 2 Tumor-Agnostic 1 Endocrine 1

Conditions

Pituitary Neoplasms 1 Pituitary Diseases 1

Interventions

Eating 5 Standard of Care 4 Radiofrequency Ablation 4 Exercise 4 Surgical Procedures, Operative 3 Radiosurgery 3 Endoscopic Mucosal Resection 3 Adrenalectomy 3 lutetium Lu 177 dotatate 2 Yoga 2 Saline Solution 2 Robotic Surgical Procedures 2 Resistance Training 2 Proton Therapy 2 Propofol 2 Palliative Care 2 Octreotide 2 Magnetic Resonance Imaging 2 Lutetium-177 2 Liquid Biopsy 2 Interviews as Topic 2 Hydrocortisone 2 Diet, Mediterranean 2 Diet 2 Desflurane 2 Data Collection 2 Conversion to Open Surgery 2 Control Groups 2 Calcium 2 3-Iodobenzylguanidine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Dexamethasone × Endocrine × Clear all

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡